Indian drug and auto exporters believe that US President Donald Trump's proposed 25% tariffs on imports will have a limited impact on their businesses. Industry leaders say competitors from other Asian countries would also be affected, keeping India’s position strong. Generic drug exports, which make up 40% of US prescriptions, are unlikely to suffer major setbacks. Auto component manufacturers, like Sona BLW Precision Forgings Ltd., also predict minimal impact, as India exports $6.69 billion worth of auto parts to the US. Experts suggest policy changes to reduce risks, including trade deals and tariff adjustments.